Hemoglobin as a biomarker for breast cancer ISSN 2753-8176 (online) (DOI: 10.13140/RG.2.2.25461.65764)
Ana Pedro 1 1. Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway, Chester CH4 9QR, United Kingdom anapedrolaboratories@gmail.com Abstract An enourmous amount of data and additional new data supports a role for hemoglobin in breast cancer. Literature Review and evidence Mammography screening is meant to reduce breast cancer (BC) mortality through early diagnosis and treatment of disease that would otherwise threaten life. However, in some cases a screening mammogram detects a cancer that would have neither caused death nor presented clinically during the woman’s lifetime (1). It is clear that to reduce the burden of over diagnosis on both the emotional and physical health of the patient and the economic health of the NHS, more sensitive tests for the diagnosis of breast cancer are needed. Preliminary data of our lab have showed that we have identified a biomarker for early stage ER+ breast cancer, HCG1745306 isoform CRA-a (2). A large body of evidence supports ...